Last quarter (Q3 2023), P3 Health Partners's total revenue was $288.35M, an increase of 16.15% from the same quarter last year. In Q3, P3 Health Partners's net income was $-13.30M. See P3 Health Partners’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 1.17B	$ 1.05B	$ 578.60M	$ 485.54M	$ 145.89M
Cost of Revenue	-	-	-	-	-
Gross Profit	$ 1.18B	$ 1.05B	$ 58.76M	-	-
Operating Expense	$ 228.43M	$ 2.61B	$ -707.66M	$ 520.66M	$ 185.43M
Operating Income	$ 423.80M	$ -1.56B	$ -65.85M	$ -35.12M	$ -39.54M
Net Non Operating Interest Income Expense	$ -11.24M	$ -11.40M	$ 2.27M	$ -9.97M	$ -3.48M
Other Income Expense	$ -11.84M	$ -12.62M	$ -793.73M	$ -290.68K	$ 97.95K
Pretax Income	$ -646.86M	$ -1.56B	$ -146.40M	$ -45.38M	$ -42.92M
Tax Provision	$ 2.79M	$ 1.86M	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	$ -126.34M	$ 1.82B	$ -17.04M	$ -41.07M	$ -35.01M
Basic EPS	$ -2.70	$ -6.50	$ -0.24	$ -0.60	$ -0.51
Diluted EPS	$ -2.68	$ -6.50	$ -0.24	$ -0.60	$ -0.51
Basic Average Shares	$ 263.27M	$ 41.58K	-	$ 68.16M	$ 68.16M
Diluted Average Shares	$ 461.75M	$ 41.58K	-	$ 68.16M	$ 68.16M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	$ 228.43M	$ 2.61B	$ 117.65M	$ 520.66M	$ 185.43M
Net Income From Continuing And Discontinued Operation	$ -169.59M	$ -270.13M	$ -17.04M	$ -41.07M	$ -35.01M
Normalized Income	$ -21.61M	$ 82.79M	-	$ -41.07M	$ -35.01M
Interest Expense	-	-	-	-	-
EBIT	$ -628.38M	$ -1.55B	$ -147.35M	$ -35.12M	$ -39.54M
EBITDA	$ -541.21M	$ -1.46B	$ -133.24M	$ -34.33M	$ -39.14M

Currency in USD

P3 Health Partners Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing